
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Syneos Health ROA 2011-2026 | SYNH
ROA Jährlich Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.85 | 2.39 | 1.76 | 0.33 | -1.9 | 8.74 | 9.66 | -1.89 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.66 | -1.9 | 2.74 |
ROA Vierteljährlich Syneos Health
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.33 | 1.11 | 2.06 | 2.46 | 2.98 | 1.96 | 2.75 | 2.58 | 2.11 | 1.25 | 2.47 | 2.48 | 2.58 | 1.76 | 1.17 | 0.24 | 0.27 | 0.33 | -0.5 | -2.39 | -2.53 | -1.9 | 1.22 | 5.37 | 7.68 | 8.74 | 8.36 | 9.36 | 8.93 | 9.66 | 3.12 | 1.01 | 0.31 | -1.9 | 1.06 | 0.05 | -1.18 | -1.05 | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.66 | -2.53 | 2.2 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
11.3 | $ 113.88 | -0.84 % | $ 34.6 B | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 24.83 | 0.4 % | $ 690 M | ||
|
Danaher Corporation
DHR
|
4.33 | $ 191.01 | -0.56 % | $ 136 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 15.91 | -3.11 % | $ 481 M | ||
|
Guardant Health
GH
|
-20.67 | $ 93.3 | 4.06 % | $ 11.7 B | ||
|
CareDx, Inc
CDNA
|
-5.17 | $ 17.67 | -0.84 % | $ 942 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
13.19 | $ 63.11 | -0.16 % | $ 24.6 B | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 107.16 | -2.24 % | $ 8.84 B | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.09 | -1.29 % | $ 173 M | ||
|
IQVIA Holdings
IQV
|
4.54 | $ 170.62 | -0.01 % | $ 29.3 B | ||
|
Co-Diagnostics
CODX
|
-189.54 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 269.17 | -1.93 % | $ 22.4 B | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Lantheus Holdings
LNTH
|
10.49 | $ 78.08 | 2.89 % | $ 5.27 B | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
22.84 | $ 508.52 | 2.52 % | $ 14.7 B | ||
|
Charles River Laboratories International
CRL
|
-2.02 | $ 169.54 | 0.78 % | $ 8.4 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
23.41 | $ 1 270.0 | 0.27 % | $ 26.2 B | ||
|
Myriad Genetics
MYGN
|
-51.78 | $ 4.74 | 1.5 % | $ 439 M | ||
|
NeoGenomics
NEO
|
-7.94 | $ 8.06 | 0.5 % | $ 1.03 B | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 9.98 | 4.39 % | $ 2.16 B | ||
|
Natera
NTRA
|
-39.28 | $ 209.27 | 2.15 % | $ 20.6 B | ||
|
Biodesix
BDSX
|
-44.15 | $ 14.53 | -5.4 % | $ 1.88 B | ||
|
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | ||
|
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.44 | 1.41 % | $ 432 M | ||
|
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | ||
|
Precipio
PRPO
|
-1.7 | $ 28.5 | 9.7 % | $ 45.7 M | ||
|
Personalis
PSNL
|
-30.08 | $ 6.17 | -6.23 % | $ 366 M | ||
|
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M | ||
|
Illumina
ILMN
|
-19.4 | $ 126.44 | -1.02 % | $ 20.1 B | ||
|
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-67.95 | $ 2.69 | 3.86 % | $ 87.3 K | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.16 | -0.46 % | $ 4.96 M | ||
|
BioNano Genomics
BNGO
|
-35.87 | $ 1.17 | 1.74 % | $ 6.37 M | ||
|
Interpace Biosciences
IDXG
|
72.63 | $ 2.0 | 1.27 % | $ 8.85 M |